Effects of antihypertensive therapy on blood pressure and left ventricular hypertrophy in patients with severe hypertension. 2000

H Sumino, and T Nakamura, and T Kanda, and T Sakamaki, and K Sato, and Y Saito, and J Hoshino, and T Kurashina, and Z Ono, and T Takahashi, and S Ichikawa, and M Kurabayashi, and R Nagai
Second Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Japan.

The mechanisms responsible for regression of left ventricular (LV) mass with antihypertensive therapy in patients with severe hypertension remain unclear. This study was designed to examine whether systolic and diastolic blood pressures are associated with changes in LV mass. Eighteen patients with essential hypertension whose average seated diastolic blood pressure was >or = 110 mm Hg were enrolled in the study. All patients were administered antihypertensive therapy and underwent M-mode echocardiography before and after 6 months of treatment. In all patients, antihypertensive treatment significantly reduced systolic blood pressure from 175 +/- 21 mm Hg at baseline to 143 +/- 22 mm Hg at 6 months (p < 0.001), and diastolic blood pressure from 116 +/- 7 mm Hg at baseline to 92 +/- 20 mm Hg at 6 months (p < 0.001). LV mass index at 6 months was significantly reduced compared to its baseline value (p < 0.05). Change (value at 6 months-value at baseline) in systolic and diastolic blood pressures correlated positively with the change in LV mass index (r = 0.61, p < 0.01 and r = 0.71, p < 0.001, respectively). The patients were divided into responders. whose LV mass regressed by > or = 10% (n = 9), and nonresponders, whose LV mass regressed by < 10% (n = 9). Systolic (p < 0.001) and diastolic (p < 0.001) blood pressures. interventricular septal thickness (p< 0.05), posterior wall thickness (p < 0.001), and LV mass index (p < 0.001) were significantly decreased in the responders, but not in the nonresponders, at 6 months compared with those at baseline. Systolic (p < 0.05) and diastolic (p < 0.05) blood pressures in nonresponders were significantly higher than those in the responders at 6 months. The changes in systolic and diastolic blood pressures did not correlate with the change in LV mass index in the responders or the nonresponders. The regression of LV mass is strongly affected by reducing blood pressure. This is the first study using antihypertensive therapy to demonstrate that a change in blood pressure correlates positively with changes in LV mass index in severely hypertensive patients.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D017379 Hypertrophy, Left Ventricular Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality. Left Ventricular Hypertrophy,Ventricular Hypertrophy, Left,Hypertrophies, Left Ventricular,Left Ventricular Hypertrophies,Ventricular Hypertrophies, Left

Related Publications

H Sumino, and T Nakamura, and T Kanda, and T Sakamaki, and K Sato, and Y Saito, and J Hoshino, and T Kurashina, and Z Ono, and T Takahashi, and S Ichikawa, and M Kurabayashi, and R Nagai
November 1979, Journal of the American Geriatrics Society,
H Sumino, and T Nakamura, and T Kanda, and T Sakamaki, and K Sato, and Y Saito, and J Hoshino, and T Kurashina, and Z Ono, and T Takahashi, and S Ichikawa, and M Kurabayashi, and R Nagai
June 1988, Current problems in cardiology,
H Sumino, and T Nakamura, and T Kanda, and T Sakamaki, and K Sato, and Y Saito, and J Hoshino, and T Kurashina, and Z Ono, and T Takahashi, and S Ichikawa, and M Kurabayashi, and R Nagai
November 1995, The New England journal of medicine,
H Sumino, and T Nakamura, and T Kanda, and T Sakamaki, and K Sato, and Y Saito, and J Hoshino, and T Kurashina, and Z Ono, and T Takahashi, and S Ichikawa, and M Kurabayashi, and R Nagai
January 1997, Bratislavske lekarske listy,
H Sumino, and T Nakamura, and T Kanda, and T Sakamaki, and K Sato, and Y Saito, and J Hoshino, and T Kurashina, and Z Ono, and T Takahashi, and S Ichikawa, and M Kurabayashi, and R Nagai
January 1990, Advances in nephrology from the Necker Hospital,
H Sumino, and T Nakamura, and T Kanda, and T Sakamaki, and K Sato, and Y Saito, and J Hoshino, and T Kurashina, and Z Ono, and T Takahashi, and S Ichikawa, and M Kurabayashi, and R Nagai
January 2001, The American journal of cardiology,
H Sumino, and T Nakamura, and T Kanda, and T Sakamaki, and K Sato, and Y Saito, and J Hoshino, and T Kurashina, and Z Ono, and T Takahashi, and S Ichikawa, and M Kurabayashi, and R Nagai
January 2022, Frontiers in cardiovascular medicine,
H Sumino, and T Nakamura, and T Kanda, and T Sakamaki, and K Sato, and Y Saito, and J Hoshino, and T Kurashina, and Z Ono, and T Takahashi, and S Ichikawa, and M Kurabayashi, and R Nagai
December 1980, Clinical science (London, England : 1979),
H Sumino, and T Nakamura, and T Kanda, and T Sakamaki, and K Sato, and Y Saito, and J Hoshino, and T Kurashina, and Z Ono, and T Takahashi, and S Ichikawa, and M Kurabayashi, and R Nagai
October 1990, Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine,
H Sumino, and T Nakamura, and T Kanda, and T Sakamaki, and K Sato, and Y Saito, and J Hoshino, and T Kurashina, and Z Ono, and T Takahashi, and S Ichikawa, and M Kurabayashi, and R Nagai
August 1992, American family physician,
Copied contents to your clipboard!